AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 91 |
Market Cap | 9.36B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 4.25 |
PE Ratio (ttm) | 21.85 |
Forward PE | n/a |
Analyst | Buy |
Ask | 95.1 |
Volume | 317,549 |
Avg. Volume (20D) | 664,427 |
Open | 92.44 |
Previous Close | 92.56 |
Day's Range | 91.33 - 92.97 |
52-Week Range | 67.94 - 104.55 |
Beta | undefined |
About EHC
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmona...
Analyst Forecast
According to 9 analyst ratings, the average rating for EHC stock is "Buy." The 12-month stock price forecast is $110, which is an increase of 18.44% from the latest price.
Next Earnings Release
Analysts project revenue of $1.38B, reflecting a 10.67% YoY growth and earnings per share of 1.02, making a 7.37% increase YoY.